Search for: "PFIZER" Results 2021 - 2040 of 4,635
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Nov 2012, 1:59 pm by Amber Walsh
Pfizer Inc. has acquired NextWave Pharmaceuticals Inc. for $782 million in cash. [read post]
27 Nov 2012, 2:00 am by Bob Denney
For more than two decades now, Bob Denney has shared his firm’s savvy observations of the most important business trends in the practice of law—not only in the United States but also in other parts of the world—via his “What’s Hot and What’s Not in the Legal Profession” reports. [read post]
26 Nov 2012, 4:00 am by Martin Kratz
Pfizer’s patent, however, was not as clear as the reputation its product enjoyed. [read post]
26 Nov 2012, 4:00 am by Martin Kratz
Pfizer’s patent, however, was not as clear as the reputation its product enjoyed. [read post]
23 Nov 2012, 10:40 am
Indian drugmaker Ranbaxy Laboratories said it issued the recall because of its generic version of Pfizer Inc.'s Lipitor because after it learned that some lots of its 10-, 20- and 40-milligram doses of the drug may contain glass. [read post]
22 Nov 2012, 6:26 pm by A. Brian Albritton
“[A]s long as Pfizer markets the drug to lower cholesterol,” the Court observed, “it is doing what the label permits. [read post]
21 Nov 2012, 11:35 pm by Michael Geist
" In this particular case, Pfizer failed to actually describe which chemical compound was effective. [read post]
21 Nov 2012, 5:00 am by Bexis
Pfizer Inc., 58 A.D.3d 138, 141 (N.Y. [read post]
19 Nov 2012, 12:29 am by Kevin LaCroix
On August 31, 2009, a Pfizer subsidiary agreed to plead guilty to a criminal felony charge. [read post]
17 Nov 2012, 3:48 am by Varun Chhonkar
No. 196774 jointly owned by OSI Pharmaceuticals and Pfizer for anticancer drug compound Erlotinib hydrochloride valid but not infringed by Cipla’s generic product Erlocip. [read post]
17 Nov 2012, 3:48 am by Varun Chhonkar
No. 196774 jointly owned by OSI Pharmaceuticals and Pfizer for anticancer drug compound Erlotinib hydrochloride valid but not infringed by Cipla’s generic product Erlocip. [read post]
16 Nov 2012, 6:14 am
This Tennessee Zoloft lawsuit claims that Pfizer was aware of the risk of side effects after taking Zoloft, but failed to adequately warn the public or the medical community. [read post]
15 Nov 2012, 9:35 am
Oral argument argued before the Eighth Circuit U.S. [read post]
8 Nov 2012, 9:47 am
The Court held that Pfizer had not fulfilled its part of that bargain and thus its (Canadian) patent was invalid. [read post]
2 Nov 2012, 11:58 am by Bexis
One of our posts earlier this week made the statement “Off-label use can be, in many circumstances, the standard of care. [read post]
30 Oct 2012, 7:36 am
Failed to Warn of Risks The argument is Pfizer failed to warn of the risks to unborn children, and further that Pfizer did not adequately test the product. [read post]
29 Oct 2012, 11:52 am
Schwarz Pharma (UCB), Pfizer and Wyeth have been granted a summary judgment amid the claim that brand name drug makers are not obligated to take care of injured Reglan users that used the drug’s generic counterpart. [read post]